Male Birth Control Pill Passes Key Safety Trial
YourChoice Therapeutics announced that YCT-529, a hormone free male contraceptive pill, completed its first in human safety trial with positive results. The clinical study marked a significant step toward expanding birth control options beyond condoms and vasectomies for men. Safety Trial Meets Primary Endpoints Researchers conducted the Phase 1a trial with sixteen healthy male volunteers…